Zhitong Finance App News, Baicheng Pharmaceutical (301096.SZ) issued an announcement. The innovative drug BIOS0635-048 tablets independently developed by the company obtained the National Drug Administration (NMPA) clinical trial approval notice, agreeing to conduct clinical trials of this single drug in advanced solid tumors.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.